NanoViricides Inc (NNVC)

[KMBJN]

You may be right, and it would explain why it has taken so long to get this far.
And yet, here they are. What would they say if they didn't go through with the trial now?

I guess this will be low cost. They reported $2.5M cash as of end of 25Q1, and 10Q from May says they think they have enough funds to run the Phase II trial in DRC for MPox.

I wanted to correct my trial overview after I went back to review the Monday PR. Phase IIa will be 10 on HSPG-cide (NV-387) vs. 10 standard of care, then Phase IIb will be a bigger trial randomized 2:1 HSPG-cide (N=40) or not (N=20) at the selected best dose.

NNVC also gave some false information (par for the course). It isn't the US CDC running/funding the MOSA trial, it is the African CDC, in combination with PANTHER, per mpx-response link.